- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003207 | Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers | completed | Phase 1 | 14 | Washington University School of MedicineOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00003925 | Combination Chemotherapy In Treating Patients With Advanced Cancer | completed | Phase 1 | 36 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00253565 | Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | Herbert HurwitzOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00016185 | Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00003956 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00084643 | GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00003406 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | completed | Phase 1 / Phase 2 | 30 | Cancer Treatment Centers of AmericaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00003703 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Jewish General HospitalOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00022295 | Phenoxodiol in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 36 | Kazia Therapeutics LimitedINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00091052 | Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | — | Sirius MedicineINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00016354 | Benzoylphenylurea in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 19 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT00084812 | Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 43 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00003368 | Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00303797 | Sorafenib and Bortezomib in Treating Patients With Advanced Cancer | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00014248 | Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Mar 18, 2013 | clinicaltrials |
| NCT00007917 | Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 58 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00823524 | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | 47 | Asan Medical CenterOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00002980 | Decitabine in Treating Patients With Melanoma or Other Advanced Cancer | completed | Phase 1 | — | California Cancer ConsortiumNETWORK | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00544284 | Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment | completed | Phase 1 | 25 | City of Hope Medical CenterOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT01101412 | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 15, 2013 | clinicaltrials |
| NCT00002862 | Perillyl Alcohol in Treating Patients With Refractory Cancer | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00002946 | Penclomedine in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003330 | Interleukin-12 in Treating Patients With Advanced Cancer | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004189 | Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004229 | Endostatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004242 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00006221 | BMS-247550 in Treating Patients With Advanced Cancers | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003249 | Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00004241 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00025415 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00027898 | Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00030615 | Decitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00287937 | Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT01602627 | Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies | terminated | Phase 1 | 2 | Dale Shepard, MD, PhDOTHER | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00002759 | Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 3 | National Cancer Institute (NCI)NIH | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00002909 | Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00003451 | Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00004079 | Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00005604 | Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00006242 | BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00066625 | Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00068484 | A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00006000 | SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00238225 | Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00275093 | Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function | completed | Phase 1 | 130 | National Cancer Institute (NCI)NIH | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00010205 | Benzoylphenylurea in Treating Patients With Advanced Cancer | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00022113 | EMD 121974 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00022529 | BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00039390 | Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 12, 2013source: clinicaltrials